BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6861143)

  • 1. A new bioactive form of human calcitonin.
    Tobler PH; Dambacher MA; Born W; Heitz PU; Maier R; Fischer JA
    Cancer Res; 1983 Aug; 43(8):3793-9. PubMed ID: 6861143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
    Rude RK; Matsumoto S; Singer FR
    Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients.
    Tobler PH; Tschopp FA; Dambacher MA; Born W; Fischer JA
    J Clin Endocrinol Metab; 1983 Oct; 57(4):749-54. PubMed ID: 6885964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identity of calcitonin extracted from normal human thyroid glands with synthetic human calcitonin-(1-32).
    Tobler PH; Jöhl A; Born W; Maier R; Fischer JA
    Biochim Biophys Acta; 1982 Sep; 707(1):59-65. PubMed ID: 7138879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
    Goltzman D; Tischler AS
    J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular forms of katacalcin, calcitonin gene-related peptide and gastrin-releasing peptide, in a human medullary thyroid carcinoma.
    Conlon JM; McGregor GP; Wallin G; Grimelius L; Thim L
    Cancer Res; 1988 May; 48(9):2412-6. PubMed ID: 3258543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin-producing pancreatic somatostatinoma.
    Galmiche JP; Chayvialle JA; Dubois PM; David L; Descos F; Paulin C; Ducastelle T; Colin R; Geffroy Y
    Gastroenterology; 1980 Jun; 78(6):1577-83. PubMed ID: 6102950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.
    Sizemore GW; Hpeath H; Larson JM
    J Clin Invest; 1975 May; 55(5):1111-8. PubMed ID: 47335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and localization of 7B2 protein in human, porcine, and rat thyroid gland and in human medullary carcinoma.
    Marcinkiewicz M; Benjannet S; Falgueyret JP; Seidah NG; Schürch W; Verdy M; Cantin M; Chrétien M
    Endocrinology; 1988 Aug; 123(2):866-73. PubMed ID: 3293987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of substance P-like immunoreactivity in human thyroid and medullary carcinoma of the thyroid.
    Kakudo K; Vacca LL
    J Submicrosc Cytol; 1983 Apr; 15(2):563-8. PubMed ID: 6687904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
    Woloszczuk W; Kovarik J
    Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation reduces the bioactivity of calcitonin.
    Gkonos PJ; Charbonneau H; Lawson PT; Howard GA; Birnbaum RS; Roos BA
    Peptides; 1989; 10(1):137-43. PubMed ID: 2748417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid.
    Morimoto S; Okada Y; Onishi T; Takai S; Miyauchi A; Lee S; Nishioka Y; Kumahara Y
    Endocrinol Jpn; 1981 Oct; 28(5):583-94. PubMed ID: 7344949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neuroendocrine peptide derived from the amino-terminal half of rat procalcitonin.
    Burns DM; Birnbaum RS; Roos BA
    Mol Endocrinol; 1989 Jan; 3(1):140-7. PubMed ID: 2915645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of Nkx2.1 and Pax9 for calcitonin gene transcription.
    Suzuki M; Katagiri N; Ueda M; Tanaka S
    Gen Comp Endocrinol; 2007; 152(2-3):259-66. PubMed ID: 17412341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic human calcitonin (Cibacalcin, Ciba-Geigy): use for radioimmunoassay and bioassay.
    Raue F; Streibl W; Ziegler R
    Endokrinologie; 1982 Feb; 79(1):118-24. PubMed ID: 7084124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin-like substance in plasma of the hagfish, Eptatretus burgeri (Cyclostomata).
    Suzuki N
    Zoolog Sci; 1995 Oct; 12(5):607-10. PubMed ID: 8590832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification, characterization and radioimmunoassay of thyrocalcitonin from rat thyroid glands.
    Burford HJ; Ontjes DA; Cooper CW; Parlow AF; Hirsch PF
    Endocrinology; 1975 Feb; 96(2):340-8. PubMed ID: 46198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin-like immunoreactivity in mammalian thyroid glands: contents and partial characterization.
    Oyama H; Kameda Y; Endoh M; Nagase Y; Matsuki M; Kakita K; Tenku A; Nishida S; Horino M
    Endocrinology; 1984 Mar; 114(3):1028-32. PubMed ID: 6141931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against calcitonin. Characterization and application in light and electron microscopy immunocytochemistry.
    Scopsi L; Arias J; Houen G; Racchetti G; Fossati GL; Galante YM
    Histochemistry; 1988; 88(2):113-25. PubMed ID: 3346173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.